Finally, a quick reminder that when using terms underlying and adjusted, management is referring to non-GAAP financial measures.
Otherwise, they are referring to GAAP results.
"We were encouraged by the clear signs of recovery during the second quarter.
Vaccine adoption in key regions have contributed to an increasing number of patients seeking and, most importantly, receiving treatment.
Last year, we noted that we're in the midst of the onset of this tragic global pandemic.
There were more than 20,000 patients around the world who were treated with our SAPIEN valves in that second quarter.
We are pleased to report better than expected second quarter sales of $1.4 billion, up 44% on a constant currency basis from a year ago period.
All four product groups delivered large increases in sales led by TAVR.
